- Home
- FISI vs CYRX Comparison
FISI vs CYRX Comparison
Compare FISI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FISI
- CYRX
- Stock Information
- Founded
- FISI 1817
- CYRX 1999
- Country
- FISI United States
- CYRX United States
- Employees
- FISI N/A
- CYRX N/A
- Industry
- FISI Major Banks
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- FISI Finance
- CYRX Health Care
- Exchange
- FISI Nasdaq
- CYRX Nasdaq
- Market Cap
- FISI 500.2M
- CYRX 438.7M
- IPO Year
- FISI 1999
- CYRX N/A
- Fundamental
- Price
- FISI $25.78
- CYRX $8.61
- Analyst Decision
- FISI Buy
- CYRX Strong Buy
- Analyst Count
- FISI 3
- CYRX 10
- Target Price
- FISI $33.00
- CYRX $11.70
- AVG Volume (30 Days)
- FISI 133.9K
- CYRX 1.1M
- Earning Date
- FISI 07-24-2025
- CYRX 08-05-2025
- Dividend Yield
- FISI 4.77%
- CYRX N/A
- EPS Growth
- FISI N/A
- CYRX N/A
- EPS
- FISI N/A
- CYRX 1.35
- Revenue
- FISI $102,639,000.00
- CYRX $237,879,000.00
- Revenue This Year
- FISI $122.14
- CYRX N/A
- Revenue Next Year
- FISI $4.97
- CYRX $9.36
- P/E Ratio
- FISI N/A
- CYRX $6.38
- Revenue Growth
- FISI N/A
- CYRX 14.20
- 52 Week Low
- FISI $20.97
- CYRX $4.58
- 52 Week High
- FISI $29.79
- CYRX $9.66
- Technical
- Relative Strength Index (RSI)
- FISI 48.83
- CYRX 58.03
- Support Level
- FISI $24.62
- CYRX $7.51
- Resistance Level
- FISI $26.72
- CYRX $9.33
- Average True Range (ATR)
- FISI 0.78
- CYRX 0.64
- MACD
- FISI 0.09
- CYRX 0.11
- Stochastic Oscillator
- FISI 55.24
- CYRX 68.82
About FISI Financial Institutions Inc.
Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.